Drugs.com Headline News
- Dupixent (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for...on April 18, 2025 at 12:04 am
TARRYTOWN, N.Y. and PARIS, April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) […]
- U.S. Food and Drug Administration Updates Camzyos (mavacamten) Label to Reduce Echocardiography...on April 17, 2025 at 11:04 pm
PRINCETON, N.J.-- April 17, 2025 -- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for Camzyos […]
- FDA Grants Isturisa (osilodrostat) Expanded Indication for the Treatment of Endogenous...on April 16, 2025 at 2:04 am
Milan, Italy and Bridgewater, NJ, April 16, 2025 – Today Recordati announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Isturisa (osilodrostat) for […]
- Neurelis Announces FDA Approval for Immediate Use Seizure Medication Valtoco (diazepam nasal spray)...on April 16, 2025 at 1:04 am
San Diego, CA – April, 16, 2025 – Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam nasal spray) for short-term treatment of seizure clusters (also known […]
Latest Medical News MedicineNet
These health news headlines are provided courtesy of MedicineNet.
- Feed has no items.
- Feed has no items.
These health news headlines are provided courtesy of MedicineNet.